Filing Details

Accession Number:
0001123292-20-001279
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-18 17:35:31
Reporting Period:
2020-12-16
Accepted Time:
2020-12-18 17:35:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882104 Pdl Biopharma Inc. PDLI Biological Products, (No Disgnostic Substances) (2836) 943023969
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1029625 A Edward Mule Two Greenwich Plaza, First Floor
Greenwich CT 06830
No No Yes No
1332784 L.p. Capital Point Silver Two Greenwich Plaza, First Floor
Greenwich CT 06830
No No Yes No
1382617 J Robert O'shea Two Greenwich Plaza, First Floor
Greenwich CT 06830
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-16 1,350,000 $2.58 14,863,460 No 4 P Direct
Common Stock Acquisiton 2020-12-17 398,000 $2.61 15,261,460 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct